fMRI Study Examining Effects of D-cycloserine in Specific Phobia
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The research team hopes to use brain imaging and mental testing to learn more about specific
phobias and the treatment of phobia. When given directly prior to therapy sessions,
D-cycloserine has been shown to enhance the effects of therapy. This study hopes to identify
reasons why D-cycloserine has this effect by measuring brain activity.
Phase:
Phase 2
Details
Lead Sponsor:
Cary Savage, Ph.D. University of Kansas Medical Center
Collaborators:
American Psychological Association American Psychological Foundation University of Kansas